These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27573925)

  • 1. Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
    Bidinotto LT; Véo CA; Loaiza EA; De França AP; Lorenzi AT; Rosa LA; De Oliveira CM; Levi JE; Scapulatempo-Neto C; Longatto-Filho A; Reis RM
    Mol Med Rep; 2016 Oct; 14(4):3791-7. PubMed ID: 27573925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and BRAF mutations in anal carcinoma.
    Serup-Hansen E; Linnemann D; Høgdall E; Geertsen PF; Havsteen H
    APMIS; 2015 Jan; 123(1):53-9. PubMed ID: 25244542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
    PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
    Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
    Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.
    Zhang J; Martins CR; Fansler ZB; Roemer KL; Kincaid EA; Gustafson KS; Heitjan DF; Clark DP
    Clin Cancer Res; 2005 Sep; 11(18):6544-9. PubMed ID: 16166431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS and BRAF mutations in sinonasal cancer.
    López F; García Inclán C; Pérez-Escuredo J; Alvarez Marcos C; Scola B; Suárez C; Llorente JL; Hermsen MA
    Oral Oncol; 2012 Aug; 48(8):692-7. PubMed ID: 22459936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation.
    Baba Y; Ishimoto T; Harada K; Kosumi K; Murata A; Miyake K; Hiyoshi Y; Kurashige J; Iwatsuki M; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Oki E; Iyama K; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Oct; 22(11):3659-65. PubMed ID: 25691283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.
    Sendagorta E; Herranz P; Guadalajara H; Bernardino JI; Viguer JM; Beato MJ; García-Olmo D; Peña JM
    Dis Colon Rectum; 2014 Apr; 57(4):475-81. PubMed ID: 24608304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
    Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
    Walcheck MT; Matkowskyj KA; Turco A; Blaine-Sauer S; Nukaya M; Noel J; Ronnekleiv OK; Ronnekleiv-Kelly SM
    PLoS One; 2021; 16(11):e0259245. PubMed ID: 34735515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
    Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
    J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF and KRAS mutations in prostatic adenocarcinoma.
    Cho NY; Choi M; Kim BH; Cho YM; Moon KC; Kang GH
    Int J Cancer; 2006 Oct; 119(8):1858-62. PubMed ID: 16721785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer.
    Nicoś M; Krawczyk P; Jarosz B; Sawicki M; Szumiłło J; Trojanowski T; Milanowski J
    Clin Exp Med; 2016 May; 16(2):169-76. PubMed ID: 25902737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.